Upfront allo-HSCT after intensive chemotherapy for untreated aggressive ATL: A single arm, phase 3 trial, JCOG0907
The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD
Early Use of Luspatercept After Allogeneic HSCT Improves Erythroid Recovery and Transfusion Burden
Implementation and Effectiveness of an eHealth supported integrated care model for patients after hematopoietic cell transplantation: The Swiss SMILe hybrid effectiveness-implementation RCT
Low-Intensity Pretransplant Therapy in Acute Myeloid Leukemia: A 13-Year Single-Center Experience
Busulfan pharmacokinetics in adults – a real-world evaluation of intra-individual variabil-ity and the impact of obesity and deferasirox
Risk Factors for Alloimmune Lung Syndromes after Allogeneic Hematopoietic Cell Transplantation in Children
The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT
Adjusting Disease Risk Index for Regional Variations and Donor Selection: TRUMP cohort study
Frequency and Impact of Somatic Co-occurring Mutations on Post-Transplant Outcomes in Acute Myeloid Leukemia: A Multicenter Registry Analysis on Behalf of the EBMT ALWP